{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:ct-nct06845202",
  "owner": "cardio",
  "kind": "study",
  "slug": "nct06845202",
  "name": "A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM",
  "aliases": [
    "NCT06845202"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 105 participants.",
  "summary_technical": "Registry record NCT06845202. Randomized; triple masking; primary purpose treatment. Start 2025-03-03 (actual); primary completion 2027-08-31 (anticipated). Results not posted.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-18",
  "last_evidence_check": null,
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "nct",
      "value": "NCT06845202",
      "normalized_value": "NCT06845202",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "euct",
      "value": "2024-519005-35-00",
      "normalized_value": "2024-519005-35-00",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "condition-area": [
        "diabetes-and-metabolic-disease"
      ],
      "system": [
        "metabolism"
      ]
    }
  },
  "payload": {
    "design": "Interventional study; randomized; triple masking; primary purpose treatment",
    "drug_phase": "1/2",
    "registry_statuses": [
      {
        "status": "ACTIVE_NOT_RECRUITING",
        "snapshot": "cardio:ctgov-nct06845202-2026-11-16"
      }
    ],
    "start_date": {
      "date": "2025-03-03",
      "type": "actual",
      "snapshot": "cardio:ctgov-nct06845202-2026-11-16"
    },
    "primary_completion_date": {
      "date": "2027-08-31",
      "type": "anticipated",
      "snapshot": "cardio:ctgov-nct06845202-2026-11-16"
    },
    "completion_date": {
      "date": "2027-08-31",
      "type": "anticipated",
      "snapshot": "cardio:ctgov-nct06845202-2026-11-16"
    },
    "results_first_posted": null,
    "countries": [
      {
        "code": "US",
        "snapshot": "cardio:ctgov-nct06845202-2026-11-16"
      },
      {
        "code": "AR",
        "snapshot": "cardio:ctgov-nct06845202-2026-11-16"
      },
      {
        "code": "CA",
        "snapshot": "cardio:ctgov-nct06845202-2026-11-16"
      },
      {
        "code": "CL",
        "snapshot": "cardio:ctgov-nct06845202-2026-11-16"
      },
      {
        "code": "DE",
        "snapshot": "cardio:ctgov-nct06845202-2026-11-16"
      },
      {
        "code": "PL",
        "snapshot": "cardio:ctgov-nct06845202-2026-11-16"
      }
    ],
    "care_setting": null,
    "stopped_early": null,
    "enrollment": [
      {
        "count": 105,
        "basis": "enrolled",
        "unit": "participants",
        "snapshot": "cardio:ctgov-nct06845202-2026-11-16"
      }
    ],
    "arms": [],
    "findings": [],
    "registry": [
      {
        "label": "Brief title",
        "value": "A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM",
        "locator": "protocolSection.identificationModule.briefTitle"
      },
      {
        "label": "Condition",
        "value": "Obese or Overweight Healthy Volunteers",
        "locator": "protocolSection.conditionsModule.conditions[0]"
      },
      {
        "label": "Condition",
        "value": "Type 2 Diabetes Mellitus (T2DM)",
        "locator": "protocolSection.conditionsModule.conditions[1]"
      },
      {
        "label": "Intervention (Drug)",
        "value": "ALN-4324",
        "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
      },
      {
        "label": "Intervention (Drug)",
        "value": "Placebo",
        "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
      },
      {
        "label": "Lead sponsor",
        "value": "Alnylam Pharmaceuticals",
        "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.name"
      },
      {
        "label": "Lead sponsor class",
        "value": "INDUSTRY",
        "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.class"
      }
    ]
  },
  "content_digest": "de06973b6a1fc846ea2ad74f465428c63a63b841be49d0323c26b2a924fb11ad",
  "review": {
    "content_digest": "de06973b6a1fc846ea2ad74f465428c63a63b841be49d0323c26b2a924fb11ad",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "investigates",
        "label": "Registry condition terms include this condition",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:type-2-diabetes",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct06845202-2026-11-16",
          "locator": "derivedSection.conditionBrowseModule.meshes[1].id"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "sponsored_by",
        "label": "Registry lists this organization as the lead sponsor",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:org-alnylam-pharmaceuticals",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct06845202-2026-11-16",
          "locator": "protocolSection.sponsorCollaboratorsModule.leadSponsor.name"
        },
        "primary": false,
        "role": "lead",
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": []
  },
  "page_path": "studies/nct06845202/",
  "context_path": "api/v1/context/cardio--ct-nct06845202.md"
}
